Insider · CIK 0001735382

Schranz Jennifer

Reports to the SEC for 1 company · KING OF PRUSSIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001735382

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-28	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−33 sh	$2.39	−$78.87	39,125
2021-01-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−36 sh	$2.62	−$94.32	39,158
2021-01-29	Nabriva Therapeutics plcA Award	Chief Medical Officer	AAward	+22.5K sh	—	—	39,194
2020-12-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−30 sh	$2.42	−$72.6	16,694
2020-11-30	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.43	−$128.527	167,240
2020-10-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.50	−$149.146	167,541
2020-09-30	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.53	−$160.433	167,842
2020-08-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.62	−$186.439	168,143
2020-07-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.76	−$228.76	168,444
2020-06-30	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.67	−$203.055	168,745
2020-05-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$1.14	−$343.14	169,046
2020-04-30	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.55	−$165.038	169,347
2020-03-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$0.57	−$173.075	169,648
2020-02-28	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−301 sh	$1.35	−$406.35	169,949
2020-02-06	Nabriva Therapeutics plcA Award	Chief Medical Officer	AAward	+105K sh	—	—	158,705
2020-02-06	Nabriva Therapeutics plcStock OptionsA Award	Chief Medical Officer	AAward	+210K sh	—	—	210,000
2020-01-31	Nabriva Therapeutics plcF Tax Payment	Chief Medical Officer	FTax Payment	−4,295 sh	$1.35	−$5,798.25	53,705
2019-01-31	Nabriva Therapeutics plcStock OptionsA Award	Chief Medical Officer	AAward	+235K sh	—	—	235,000
2019-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Chief Medical Officer	AAward	+52.5K sh	—	—	52,500
2018-06-22	Nabriva Therapeutics plcP Purchase	Chief Medical Officer	PPurchase	+5,500 sh	$3.73	+$20.5K	5,500
2018-03-30	Nabriva Therapeutics plcStock OptionA Award	Chief Medical Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Mar 24
Schranz Jennifer0001104659-21-030948
SEC(opens sec.gov)
Feb 24
Schranz Jennifer0001104659-21-011104
SEC(opens sec.gov)
Jan 54
Schranz Jennifer0001104659-21-001030
SEC(opens sec.gov)
Dec 14
Schranz Jennifer0001104659-20-131221
SEC(opens sec.gov)
Nov 24
Schranz Jennifer0001104659-20-120640
SEC(opens sec.gov)
Oct 14
Schranz Jennifer0001104659-20-111077
SEC(opens sec.gov)
Sep 24
Schranz Jennifer0001104659-20-101906
SEC(opens sec.gov)
Aug 44
Schranz Jennifer0001104659-20-090282
SEC(opens sec.gov)
Jul 24
Schranz Jennifer0001104659-20-080541
SEC(opens sec.gov)
Jun 34
Schranz Jennifer0001104659-20-069180
SEC(opens sec.gov)
May 44
Schranz Jennifer0001104659-20-056351
SEC(opens sec.gov)
Apr 24
Schranz Jennifer0001104659-20-042578
SEC(opens sec.gov)
Mar 34
Schranz Jennifer0001104659-20-028849
SEC(opens sec.gov)
Feb 104
Schranz Jennifer0001104659-20-015178
SEC(opens sec.gov)
Feb 44
Schranz Jennifer0001104659-20-010902
SEC(opens sec.gov)
Feb 44
Schranz Jennifer0001104659-19-005519
SEC(opens sec.gov)
Jun 254
Schranz Jennifer0001104659-18-041954
SEC(opens sec.gov)

Companies

Nabriva Therapeutics plcChief Medical Officer

Address

1000 CONTINENTAL DRIVE SUITE 600

KING OF PRUSSIA, PA, 19406